LET003 | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

72 results for “LET003”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

A Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, Immunogenicity, and Preliminary Efficacy of SGT003 in Patients With Advanced Solid Tumors

332 participants · First posted Sep 9, 2026

SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors

37 participants · First posted Apr 29, 2022

Not yet recruiting

SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors

34 participants · First posted Sep 1, 2022

Active, not recruiting

A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors

111 participants · First posted Feb 16, 2023

Open-Label Extension to Evaluate the Longer Term Efficacy and Safety of LIB003

32 participants · First posted Feb 20, 2019

PT003 MDI Dose Confirmation Study

185 participants · First posted May 9, 2011

PT003 MDI Cardiovascular Safety Study

237 participants · First posted May 9, 2011

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

71 participants · First posted Jul 14, 2026

Not yet recruiting

LMT503 First-in-human SAD, MAD, and FE Study

72 participants · First posted Dec 21, 2022

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

64 participants · First posted Dec 17, 2007

Page 1 of 6